Authors:
Shimoyama, M
Shimoyama, N
Zhao, GM
Schiller, PW
Szeto, HH
Citation: M. Shimoyama et al., Antinociceptive and respiratory effects of intrathecal H-Tyr-D-Arg-Phe-Lys-NH2 (DALDA) and [Dmt(1)]DALDA, J PHARM EXP, 297(1), 2001, pp. 364-371
Citation: Hh. Szeto et al., Resensitization of blood pressure response to mu-opioid peptide agonists after acute desensitization, ANESTH ANAL, 93(3), 2001, pp. 581-586
Authors:
Omoniyi, AT
Kett, A
Wu, DL
Soong, Y
Clapp, JF
Szeto, HH
Citation: At. Omoniyi et al., A peripheral site of action for the attenuation of baroreflex-mediated bradycardia by intravenous mu-opioid agonists, J CARDIO PH, 35(2), 2000, pp. 269-274
Citation: Ml. Arndt et al., Nociceptin/orphanin FQ increases blood pressure and heart rate via sympathetic activation in sheep, PEPTIDES, 20(4), 1999, pp. 465-470
Authors:
Szeto, HH
Soong, Y
Wu, DL
Olariu, N
Kett, A
Kim, H
Clapp, JF
Citation: Hh. Szeto et al., Respiratory depression after intravenous administration of delta-selectiveopioid peptide analogs, PEPTIDES, 20(1), 1999, pp. 101-105
Citation: Hh. Szeto et al., The role of N-methyl-D-aspartate receptors in the release of adrenocorticotropin by dynorphin A(1-13), NEUROENDOCR, 69(1), 1999, pp. 28-33
Authors:
Holsey, YS
Wu, DL
Soong, Y
Omoniyi, AT
Szeto, HH
Citation: Ys. Holsey et al., Cardiovascular effects of a mu-selective opioid agonist (tyrosine-D-arginine-phenylalanine-lysine-NH2) in fetal sheep: Sites and mechanisms of action, AM J OBST G, 180(5), 1999, pp. 1127-1130